Literature DB >> 17541764

Ischemic infarction following an intra-cerebral hemorrhage in an adult sickle cell disease with angiographic Moyamoya.

Praveen Kumar Gupta1, Krishnan Pudukode Ramnath, Prabha Ramadorai, Abdulla Alajmi, Janaki Sudhakar Praharaju.   

Abstract

A 43-year-old lady, known case of sickle cell disease (SCD) was admitted in sickle cell crises and developed a left frontal intracerebral hematoma. She worsened further neurologically and was found to have developed a large left middle cerebral artery (MCA) infarct. Angiogram showed Moyamoya pattern. The patient was managed conservatively with exchange transfusions and made good recovery. She is being maintained on monthly exchange transfusions and hydroxyurea. Such a presentation has been described infrequently, that too mostly in children. Only once, it has been reported with adult SCD. Diagnostic and management controversies are discussed in the light of available literature.

Entities:  

Mesh：

Year:  2007        PMID： 17541764     DOI： 10.1007/s11239-007-0050-8

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


  15 in total

1.  Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.

Authors:  Gregory J Kato; Vicki McGowan; Roberto F Machado; Jane A Little; James Taylor; Claudia R Morris; James S Nichols; Xunde Wang; Mirjana Poljakovic; Sidney M Morris; Mark T Gladwin
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

2.  Hemorrhage predisposing to cerebral infarction in children with moyamoya disease.

Authors:  Mubeen F Rafay; Sabrina E Smith; Peter Dirks; Derek Armstrong; Gabrielle A deVeber
Journal:  Pediatr Neurol       Date:  2006-05       Impact factor: 3.372

3.  [Cases similar to cerebrovascular moyamoya disease--investigation by angiography and computed tomography].

Authors:  N Tomura; A Inugami; S Higano; H Fujita; T Abe; F Shishido; K Uemura
Journal:  No To Shinkei       Date:  1988-10

4.  Surgical therapy for adult moyamoya disease. Can surgical revascularization prevent the recurrence of intracerebral hemorrhage?

Authors:  K Houkin; H Kamiyama; H Abe; A Takahashi; S Kuroda
Journal:  Stroke       Date:  1996-08       Impact factor: 7.914

Review 5.  Sickle cell anemia.

Authors:  G J Lonergan; D B Cline; S L Abbondanzo
Journal:  Radiographics       Date:  2001 Jul-Aug       Impact factor: 5.333

Review 6.  'Angiographic moyamoya' its definition, classification, and therapy.

Authors:  Y Natori; K Ikezaki; T Matsushima; M Fukui
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

Review 7.  Moyamoya disease in Korea.

Authors:  G J Yu; S Y Kim; C J Coe
Journal:  Yonsei Med J       Date:  1991-09       Impact factor: 2.759

8.  Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult moyamoya patients.

Authors:  Motohiro Morioka; Jun-Ichiro Hamada; Takayuki Kawano; Tatemi Todaka; Shigetoshi Yano; Yutaka Kai; Yukitaka Ushio
Journal:  Stroke       Date:  2003-01       Impact factor: 7.914

9.  Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions.

Authors:  C H Pegelow; R J Adams; V McKie; M Abboud; B Berman; S T Miller; N Olivieri; E Vichinsky; W Wang; D Brambilla
Journal:  J Pediatr       Date:  1995-06       Impact factor: 4.406

10.  Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure.

Authors:  Robert H Fryer; Richard C Anderson; Claudia A Chiriboga; Neil A Feldstein
Journal:  Pediatr Neurol       Date:  2003-08       Impact factor: 3.372
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.